Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
UK mid-market business growth hits 22-month high in September, NatWest says

UK mid-market business growth hits 22-month high in September, NatWest says

BitgetBitget2026/10/20 12:54
  • NatWest's tracker showed UK mid-market business activity grew at its fastest pace in 22 months in September 2026.
  • The activity index rose to 56.2 from 52.4 in August, remaining above the 50 growth threshold for a third consecutive month.
  • Services led the expansion with an index reading of 57.0; manufacturing registered 52.2.
  • The SME activity index improved to 49.8 from 47.8, signaling near-stabilization but remaining below the growth threshold.
  • Mid-market hiring reached its strongest pace in 22 months, though rising fuel and wage costs threatened the recovery.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Natwest Group plc published the original content used to generate this news brief on October 20, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

GM cancels long-term rare earth permanent magnet supply agreement in the US; supplier initiates arbitration

General Motors (GM.US) has canceled a long-term supply agreement with a U.S. rare earth permanent magnet manufacturer, and both parties are currently undergoing arbitration.

智通财经•2026/10/23 03:27
GM cancels long-term rare earth permanent magnet supply agreement in the US; supplier initiates arbitration

Allergy and autoimmune biotechnology company Lycia Therapeutics (LYCA.US) will be listed on Nasdaq tonight! IPO priced at $18 per share, aiming to raise $317.5 millions.

Lycia will issue 17.64 million shares at a price of $18 per share to raise $317.5 million.

智通财经•2026/10/23 02:47